IMC Chicago’s Zoetis ZTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$7.33M Sell
62,000
-69,600
-53% -$8.61M ﹤0.01% 1502
2025
Q4
$16.6M Sell
131,600
-3,100
-2% -$404K 0.01% 938
2025
Q3
$19.7M Buy
134,700
+71,900
+114% +$10.9M 0.01% 795
2025
Q2
$9.79M Buy
62,800
+28,200
+82% +$4.47M ﹤0.01% 1023
2025
Q1
$5.7M Sell
34,600
-15,700
-31% -$2.61M ﹤0.01% 1168
2024
Q4
$8.2M Buy
50,300
+25,800
+105% +$4.61M ﹤0.01% 1009
2024
Q3
$4.79M Buy
24,500
+4,900
+25% +$903K ﹤0.01% 1153
2024
Q2
$3.4M Buy
+19,600
New +$3.26M ﹤0.01% 1251

Other funds holding ZTS

IMC Chicago's ZTS Position: Q1 2026 in Review

IMC Chicago reduced its Zoetis (ZTS) stake by 59% in Q1 2026, selling an estimated $2.53M and leaving 13,989 shares worth $1.65M. The position accounts for ﹤0.01% of the portfolio, ranked #2765.

IMC Chicago first reported a position in ZTS in Q1 2025 and has held it in 5 quarters since. The position peaked at $5.53M in Q2 2025. 1,605 funds tracked by Wall St. Rank hold ZTS as of Q1 2026.

  • IMC Chicago held 13,989 shares of Zoetis worth $1.65M as of Q1 2026.
  • IMC Chicago sold 20,467 Zoetis shares in Q1 2026, an estimated $2.53M.
  • Zoetis made up ﹤0.01% of IMC Chicago's portfolio in Q1 2026, its #2765 holding.
  • IMC Chicago first reported a position in Zoetis in Q1 2025 and has held it in 5 quarters since.
  • IMC Chicago's Zoetis position peaked at $5.53M in Q2 2025.
  • 1,605 funds tracked by Wall St. Rank held Zoetis as of Q1 2026.

Based on IMC Chicago's 13F filing for Q1 2026, filed 5 May 2026.